RIVA-CYPROTERONE 50 MG 50 MG
CYPROTERONE ACETATE : 50 MG · DIN 02242127 · LABORATOIRE RIVA INC.
Health Canada status: CANCELLED POST MARKET
What is RIVA-CYPROTERONE 50 MG?
RIVA-CYPROTERONE 50 MG 50 MG contains CYPROTERONE ACETATE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02242127, held by LABORATOIRE RIVA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Jul-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242127 |
|---|---|
| Brand name | RIVA-CYPROTERONE 50 MG |
| Generic / active ingredient | CYPROTERONE ACETATE : 50 MG |
| Manufacturer | LABORATOIRE RIVA INC. |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G03HA01 CYPROTERONE |
| AHFS class | 24:06.06 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Jul-2003 |
| Original market date | 2000-05-15 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G03HA01 CYPROTERONE. 4 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANDROCUR | 50 MG | TABLET | AMDIPHARM LIMITED | MARKETED | DIN 00704431 |
| CYPROTERONE | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02245898 |
| MED-CYPROTERONE | 50 MG | TABLET | GENERIC MEDICAL PARTNERS INC | MARKETED | DIN 02390760 |
| RIVA-CYPROTERONE | 50 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 02395797 |
| ALTI-CPA | 50 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02229449 |
| ANDROCUR DEPOT | 100 MG | SOLUTION | AMDIPHARM LIMITED | CANCELLED POST MARKET | DIN 00704423 |
| CYPROTERONE | 50 MG | TABLET | BDH INC. | CANCELLED POST MARKET | DIN 02237253 |
| MYLAN-CYPROTERONE | 50 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02229723 |
| NOVO-CYPROTERONE | 50 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02232872 |
Who else supplies CYPROTERONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CYPROTERONE appears in 75 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.